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ABSTRACT
A specific pathogen free (SPF) barrier colony of breeding marmosets (Callithrix jacchus) was established at the
Barshop Institute for Longevity and Aging Studies. Rodent and other animal models maintained as SPF barrier
colonies have demonstrated improved health and lengthened lifespans enhancing the quality and repeatability
of aging research. The marmosets were screened for two viruses and several bacterial pathogens prior to
establishing the new SPF colony. Twelve founding animals successfully established a breeding colony with
increased reproductive success, improved health parameters, and increased median lifespan when compared
to a conventionally housed, open colony. The improved health and longevity of marmosets from the SPF barrier
colony suggests that such management can be used to produce a unique resource for future studies of aging
processes in a nonhuman primate model.

INTRODUCTION
The demographics of the U.S. population is shifting
such that the CDC estimates that by the year 2050 the
number of people over the age of 65 will double as will
the prevalence of age related disease [1]. This aging
population is predicted to increase medical, economic
and social burdens on society due to increased care
needs. In the U.S. it is estimated that more than 60% of
people over the age of 65 suffer from hypertension,
roughly 40% are obese, 21% are in fair or poor health,
and 7% need personal daily care [2-5]. Due to the
shifting demographic needs and potential health impact
on the population, research in geriatrics has recently
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shifted its focus from centering on human longevity to
improving human health span and quality of life. Aging
research is now evaluating systemic aging processes
rather than concentrating on individual diseases such as
diabetes, cardiovascular disease, Alzheimer’s, dementia,
and sarcopenia, in hopes that all of the disease
progressions will be slowed with bettered health span
for individuals [6, 7].
Animal models offer many advantages in studies of
aging and health span research. Work with rodents has
been extensive due to the fact that they are mammals
that have a relatively short lifespan [8, 9]. Mice in
particular have historically been used due to their ease
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of care, rapid developmental and reproductive rate, and
the ability to create genetic mutant lines. The ease of
manipulation has allowed extensive evaluation of
molecular mechanisms of aging, developmental and
environmental factors associated with aging, and the
effects of interventional and therapeutic treatments on
aging and health span in these species. The gold
standard for extending life span in rodent studies is the
use of caloric restriction, which has reliably increased
both lifespan and health span measures in specific
strains of mice [10-12]. Many new drugs of interest,
including rapamycin, have been tested in rodents and
continue to reveal details regarding aging and disease
progression [13-15]. However, there are many concerns
regarding the use of rodents as the only mammalian
models of aging, since many of the drugs tested in
rodents do not translate successfully to humans.
Further, inbred strains of mice often have selected traits
that are negative by-products of breeding [16].
Therefore, it is necessary to expand the comparative
biology of aging approach in conjunction with the use
of model organisms to evaluate life and health span.
Nonhuman primates offer a unique alternative for
modeling questions in aging research due to their close
relation to humans and the increased likelihood of
translation of discoveries to human diseases. In
particular, nonhuman primates may be valuable in
serving as an intermediary for intervention testing, as
has recently been demonstrated in the evaluation of
rapamycin [17-19]. However, most nonhuman primate
biomedical models have longevity longer than a
researcher’s career and are expensive to maintain and
test.
The marmoset is a small bodied, short lived primate that
has recently been developed as an alternative model for
aging research [20, 21]. Prior to 2012, the average
lifespan for marmosets was typically reported as
approximately 5-6 y, with animals considered aged at 8
y and a maximum age of 16 y [20-22]. However, two
published reports suggest that these typically reported
average and maximum lifespans do not reflect the true
lifespan potential of the species. Ridley, et al. [23]
reported on a small breeding colony at Cambridge
University in which 80% of individuals were still alive
at age 10 y and the maximum lifespan was 19 y. In
2012, a marmoset colony in Japan (CLEA) reported an
average lifespan of 12 y with a maximum of 22 y. The
dynamics in these colonies that led to the extended
lifespan is unclear, but Nishijima, et al. (2012) propose
that the extended longevity in their closed colony was
due to few infection related deaths.
Survival curves reported for marmosets typically exhibit
a normal primate linear decline in middle age rather
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than the plateaued survival typical of mouse models and
Western human populations [21]. Such a pattern
appears typical for conventionally maintained, captive
nonhuman primate populations [24]. The use of
marmosets as biomedical models for aging research
would be greatly enhanced if the marmoset longevity
curve could be reshaped to resemble the plateaued
human and mouse model curves. These plateaued
curves typically represent lower death rates in middle
age and few deaths due to illness or pathogens. The
history of mouse longevity has changed dramatically
with the introduction of barrier colony maintenance. In
the past mouse longevity resembled current primate
survivorship with linear decline in middle age.
Alterations of environmental control and medical
intervention have resulted in increased survivability and
plateaued mid-life survivorship [25, 26]. Barrier
maintenance of animal colonies typically includes
controlled entry, strict quarantine procedures,
disinfection protocols for all items into the animal
space, controlled air flow, pure dietary sources and
autoclaved water. Rodent barrier colonies implement
these strategies at varying degrees depending on strain
and risk of contamination from other sources [9].
Given the need for a short-lived nonhuman primate as a
model of aging, the reported increased longevity from
the closed Japanese colony, and the shifts in rodent
survival under barrier conditions, we developed a
barrier maintained specific pathogen free (SPF)
marmoset colony. We hypothesized that maintaining
marmosets in barrier conditions would increase
marmoset longevity, alter the survivorship curves for
marmosets and improve marmoset health measures.
This paper describes the development of that colony,
and compares health and lifespan outcomes of the SPF
colony with the conventionally housed colony from
which it was derived.

RESULTS
Establishment of SPF marmosets
Marmosets (28 males, 31 females) from Southwest
National Primate Research Center (SNPRC) were
screened for pathogens to identify potential founders for
the SPF colony. The presence of viremia was analyzed
for GB virus-A (GBV) and Callitrichine Herpes virus-3
(CHV) in 50 selected individuals. Due to the
characteristics of the two viruses processing of blood
samples differed prior to assay. CHV is a DNA virus
related to the Epstein Barr Virus, a herpes virus. The
virus is primarily present in B lymphocytes, so DNA
was purified from a total blood cell pellet for PCR.
GBV-A is an RNA virus distantly related to hepatitis C
virus, a flavivirus, and was detected in serum derived
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RNA by RT-PCR. The overall prevalence for males
and females was approximately the same for both
viruses. The small sample size did not allow an
estimation of whether the infection rate changed with
age. The prevalence for CHV in a group of 50 animals
ranging from 1-4 years of age was 60% with 20
negative animals (Table 1A). The same group had a
prevalence of 36% for GBV-A with 32 negative
animals. Repeat screening of 12 animals resulted in two
discordant values for CHV. One detected the conversion
of the animal to positive over a 19-month period and
continued confirmation of that positive result on
subsequent bleeds. Within the group of 50 animals
screened, 16 animals were double negative and suitable
for selection for the barrier colony. Animals were also
screened for the presence of fecal pathogens including
Giardia, Cryptosporidium and Clostridium perfringens
and the frequency of positive screens are shown in
Table 1B. Six females and six males were determined to
be negative for all viruses and fecal pathogens of

interest and were moved to the Texas Research Park to
found the SPF barrier colony. An assessment for viral
presence 12 months after the founding of the barrier
colony revealed one male to be positive for CHV and he
was moved back to SNPRC. No other animals were
noted to be positive for these viruses of interest at that
time, or when screened 6 years after founding the
colony. Animals from the barrier colony were screened
for fecal pathogens annually in years three, four and
five after forming the barrier colony; the rates of
positive screens are in Table 1B. Age and sex matched
animals from the conventional colony were screened for
fecal pathogens as well and the rates of positive screens
are also in Table 1B. The prevalence of
Cryptosporidium and Clostridium perfringens were
very low in both the conventional and the barrier
colony. Giardia was more prevalent than the other fecal
pathogens, though prevalence of Giardia remained
significantly lower in the barrier than in the
conventional colony (F (1,8) =5.921, p=0.041).

Table 1A. Marmosets were screened for Callitrichine Herpes virus‐3 (CHV) and GB
virus‐A (GBV) prior to entry into SPF colony. Number of animals positive/ number
of animals screened for each virus at each age screened.
CHV
Age
1
2
3-4
Total

Females
n
9/16
4/5
3/6
16/27

Males

%
56.3
80
50
59.3

n
6/10
6/8
2/5
14/23

Totals
%
60
75
40
60.9

n
15/26
10/13
5/11
30/50

%
57.7
76.9
45.5
60

%
60
12.5
40
39.1

Totals
n
12/26
2/13
4/11
18/50

%
46.2
15.4
36.4
36

GBV
Age
1
2
3-4
Total

Females
n
6/16
1/5
2/6
9/27

Males

%
37.5
20
33.3
33.3

n
6/10
1/8
2/5
9/23

Table 1B. Number of marmosets found to be positive for pathogens during the
screening process for the formation of the SPF colony, during the barrier maintenance
screening, and from the conventional colony as comparison.

Initial Screen
Barrier
Maintenance
Conventional
Comparison
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Sex
Female
Male
Female
Male
Female
Male

Number
15
18
28
19
16
12

Giardia
4
5
2
2
5
2
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Cryptosporidium
1
1
0
0
0
0

Clostridium
perfringens
2
0
0
0
1
4
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Colony growth

for experimental deaths, 89.2% survived to six months,
81% to 12 months, and 68.4% survived to 18 months.

The colony began with a single breeding pair that was
imported in July 2007, followed by three pairs in July
2008 and four more individuals between August 2009
and April 2010. These founding six breeding pairs
produced 36 litters. Breeding pairs of unrelated
individuals were formed when the animals were at least
two years old and between December 2007 and August
2016 the SPF barrier colony produced 98 litters
consisting of 275 infants from 27 breeding females and
23 breeding males. The litters in the colony consisted of
four aborted pregnancies of unknown litter size, three
singletons, 20 twin, 53 triplet, 17 quadruplet and one
quintuplet litter. The reproductive outcomes are
summarized in Table 2. Overall the reproduction in the
barrier colony was comparable to that reported for other
colonies including the conventionally housed SNPRC
colony (Table 2). On average the barrier colony
produced two surviving infants per female per year
while the SNPRC colony produces 1.6-1.8 infants per
female per year. The use of rotational hand rearing in
the barrier, which consisted of the rotational removal of
a single infant from the family group for daily
supplementation and return to the family each day, led
to higher survival rates amongst triplet litters than those
litters in which it wasn’t implemented. For triplet litters
in which all infants were born alive, rotational rearing
resulted in 83.3% of infants surviving through the first
14 days, while not implementing rotational rearing
resulted in 50.6% of infants surviving. If litters that were
rotationally reared were removed from the analysis
97.1% of infants that survived to 14 days in the barrier
colony survive to six months, 97.1% to 12 months, and
97.1% to 18 months meaning there was no loss of infants
between the ages of six months and 18 months in the SPF
colony. In comparison to infants at SNPRC that were not
rotationally reared, lived to 14 days, and were censored

Longevity in barrier
Maintaining marmosets in barrier conditions
significantly increased the survival of animals, and adult
survivorship plateaued in both males and females when
compared to marmosets maintained in conventional
housing protocols at SNPRC (Figure 1). We compared
survival in a population of 247 barrier animals (115
females and 132 males) versus a population of 370
conventionally housed animals (173 females and 197
males) over a 10-year period. Barrier females had a
median lifespan of 8.9 y (95% CI 5.9+ y, upper
confidence limit could not be determined due to
censoring) compared to a median lifespan of 4.86 y
(95% CI 4.06 to 6.38 y) at the primate center with a
hazard ratio relative to barrier females of 2.8 (p =
0.001). The female barrier survivorship curve displays a
predicted precipitous decline at 9 y which we believe
was due to the fact that the longest lived females died,
while many middle-aged females were still alive and
censored. We remain confident that a difference
between the colonies exists based on the Cox
proportional hazard analysis and the differences in the
median lifespan and their confidence limits. Further,
barrier males had a median lifespan of 8.64 y (95% CI
7.6+ y, upper limit could not be determined due to
censoring) compared to the 5.08 y (95% CI 4.33 to 7.61
y) at SNPRC with a hazard ratio relative to barrier of
3.44 (p =0.001). Because the populations were tracked
for no more than 10 years, there is not a valid lifespan
comparison of the SPF colony data with that from the
CLEA colony in Japan (Nishijima et al.,2012).
However, the early to mid-adulthood survival
percentages suggest that the barrier and CLEA
populations are similar (Table 3).

Table 2A. Reproductive outcome for the Barshop SPF barrier colony and the conventional colony at SNPRC.
Infant Outcome
Colony
SPF Barrier
SNPRC

Pregnancies
98
236

# of infants
275
630

# abort
11
27

# stillbirth
28
10

# infants surviving
to 14 days
141
252

% Survival
to 14 days
51
40

Table 2B. Reproductive outcome for the Barshop SPF barrier colony and the
conventional colony at SNPRC.
Colony
SPF Barrier
SNPRC
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Single
3
10

Litter Size
Twin
Triplet
20
53
78
114

2547

Quad
17
28

Quintuplet
1
2
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Figure 1. (A) Probability of survival for female marmosets in the Barshop SPF barrier colony and the
conventionally housed SNPRC colony. (B) Probability of survival for males.

Table 3. Age‐ and sex‐specific survival percentages for barrier colony, CLEA closed
colony and SNPRC conventionally‐housed, open colony. (* from Nishijima et al., 2012).
Colony
Barrier
CLEA*
SNPRC
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Sex
Male
Female
Male
Female
Male
Female

Survival
2 years
100
100
95
92
78
80
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5 years
90
80
92
78
60
50

8 years
68
68
87
62
38
22
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Health outcome
There were significant differences in the blood cell
counts of barrier and SNPRC animals, including white
blood cell (F (1,42) = 14.586, p<0.001), monocyte (F
(1,42) = 14.808, p<0.001) and neutrophils (F (1,42) =
17.208, p<0.001) (Table 4). Matched comparison of
blood chemistry values also showed significant
differences between colonies for albumin (F1,26) =
8.032, p=0.009), globulin (F1,26) = 8.019, p = 0.009),
and A/G ratio (F (1,26) =11.075, p=0.003). Regardless
of which colony the animal was from, age was
significantly correlated with lymphocyte count (r = 0.311, p=0.04), alkaline (r= 0.551, p=0.002), globulin
(r= 0.57, p=0.001), BUN (r= -0.434, p=0.17), A/G (r= 0.516, p=0.003), and BC (r= -0.425, p=0.019). There
were no significant changes in blood parameters for
individuals over the 18 months of sampling regardless
of location. There were also no significant differences
in any measured urinary parameters between the
locations.
There were very few adult deaths during the tenure of
the barrier colony. There were only 12 female deaths
and 7 male deaths from the original founders and the
141 animals that survived past the age of 14 days. From

these deaths there were only a few for which conclusive
pathology and cause of death were determined. A male
age 4.5 y died from congestive heart failure and
epilepsy. A male 2 y old appears to have died due to
complications associated with diabetes. A male juvenile
age 6 months died from congenital pancreatic failure.
Siblings age 3.5 y died unexpectedly, the male from
congenital gastrointestinal defect and the female from
anemia. A female 4.5 y died from postpartum complications. A female’s death was associated with cardiac
and renal failure at 4.3 y. For several deaths in the
colony we do not have conclusive pathology or cause of
death, we present here anecdotal symptomology noted
around time of death. A male age 7.6 y was found with
a rectal prolapse of unknown etiology immediately prior
to death. A female age 9 y exhibited signs of dehydration following infant delivery shortly prior to her death.
Her mate age 8.6 y was noted to have enlarged
hardened kidneys during a physical prior to his death of
unknown cause. One infant male age 22 days was
being supplemented with formula and may have
aspirated during feeding. For the other 11 deaths there
were no reported clinical symptoms or signs prior to
death. There is no evidence from the pathology reports
that any animals in the barrier died due to inflammatory
gastrointestinal or infectious disease.

Table 4. Average blood chemistry values (+ standard error) for marmosets maintained in the
Barshop SPF barrier colony and the conventional SNPRC marmoset colony (*significant at p< 0.05).
Test

SPF Barrier

SNPRC

Normal Range

UNIT

WBC*

6.06 + 0.06

10.7 + 0.09

1.8 - 8.1

(Thous/MM3)

BASO

0.08 + 0.02

0.13 + 0.03

0 - 0.1

(Thous/MM3)

EOS

0.05 + 0.02

0.1 + 0.03

0 - 0.2

(Thous/MM3)

MONO*

0.29 + 0.04

0.86 + 0.2

0 - 0.6

(Thous/MM3)

LYMPHS

3.7 + 0.4

4.2 + 0.4

0.7 - 5.0

(Thous/MM3)

NEUT*

2.6 + 0.3

5.4 + 0.7

1.5 - 8

(Thous/MM3)

ALK

138.4 + 19.3

183.5 + 22.2

5 - 113

U/L

ALT

13.2 + 3.9

15.9 + 4.6

0 - 62

U/L

ALBUMIN*

4.6 + 0.09

4.2 + 0.11

2.9 - 5.2

g/dL

PROTEIN

7.4 + 0.12

7.35 + 0.14

5.2 - 8.1

g/dL

GLOBULIN*

2.77 + 0.08

3.15 + 0.1

2.1 - 3.2

g/dL

BUN

27.97 + 1.46

25.1 + 1.7

12 - 31

mg/dL

CREATININE

0.36 + 0.02

0.4 + 0.02

0.3 - 0.5

mg/dL

GLUCOSE

166.9 + 12.2

152.5 + 14.04

92 - 244

mg/dL

A/G RATIO*

1.68 + 0.06

1.37 + 0.07

1.1 - 2

B/C RATIO

80.3 + 4.7

63.1 + 5.4

30 - 81.2
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Figure 2. (A) Hierarchical clustering of marmoset gastrointestinal microbiomes from Barshop SPF barrier colony (Barrier) and
the conventionally housed SNPRC colony (Center). (B) Frequency of taxa used in the cluster analysis, ordered by position in (A).

Table 5. Frequency of microbiome clusters in the Barshop SPF
barrier colony and the conventional SNPRC marmoset colony
(significant at p< 0.002).
Colony (n)
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Cluster 1

Cluster 2

Cluster 3

Barrier (38)

16%

10%

74%

Conventional (16)

62%

13%

25%
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By contrast, in the comparative SNPRC population
there were five deaths of animals under the age of one
year for which the cause of death was determined to be
necrotizing colitis, two that were noted as failure to
thrive infants with extensive amyloidosis, two with
Pseudomonas septicemia, and three with diarrhea
associated with colitis. Between the ages of one year
and two years four animals died due to necrotizing
colitis, eight deaths were colitis associated, three deaths
were associated with pneumonia, one death was due to
cholangitis, two deaths were a result of trauma, and two
were associated with amyloidosis. For animals aged 2-5
y there was one death associated with necrotizing
colitis, six due to colitis, one due to pneumonia, one due
to cholangitis, five associated with amyloidosis, two
individuals with lymphoma, three deaths due to
nephritis, one animal died due to cardiomegaly, and one
female died during delivery due to dystocia. For
animals between the ages of 5 -8 y there were seven
deaths associated with colitis, one death due to
cholangitis, one death due to lymphoma, one associated
with nephritis and one female death due to postpartum
complications. For animals over the age of eight there
were two deaths associated with colitis, two deaths due
to amyloidosis, three deaths due to nephritis, and five
deaths due to cardiomyopathy.
Microbial communities
The lack of gastrointestinal problems in the SPF barrier
colony and the litany of gastrointestinal problems
observed in the SNPRC animals might be linked to
differences in the composition and function of microbial
communities in their gastrointestinal tracts. Sequences
of the 16S ribosomal RNA gene were used to characterize microbial community composition for each of 38
SPF marmosets and 16 SNPRC marmosets. A subset of
19 microbial taxa were used in the comparison because
these taxa occurred in at least one sample at a frequency
of 5%. A hierarchical cluster analysis of the microbial
communities based upon the frequencies of these taxa
was performed (Figure 2). This analysis showed that the
gastrointestinal microbiomes of barrier and SNPRC
animals differed in terms of the kinds and abundances
of various bacterial taxa (Figure 2B). There were three
major clusters that grouped together microbiomes with
similar bacterial compositions. The frequencies of the
clusters in the two colonies were significantly different
(Table 5; χ2= 12.8, simulations=5,000, p-value< 0.002)
[27].
The frequencies of Bifidobacterium and Fusobacterium
B (a group that is mischaracterized as Clostridium XIX)
largely determined membership within a given cluster,
and they were negatively correlated with each other
(Figure 2). Thus, communities in Cluster 1, which was
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the predominant type in the SNPRC colony, had
comparatively high frequencies of Fusobacterium B
(>6%, median=27%) and low frequencies of
Bifidobacterium (<8%, median=4%). In contrast,
communities in Cluster 3, which was predominant in
the barrier colony, had higher frequencies of
Bifidobacterium (median=17%) and lower frequencies
of Fusobacterium B (median=1%) with only a single
exception, which had high frequencies of both.
Communities of Cluster 2 had the highest frequencies of
Bifidobacterium, >50% (median=70%) and the lowest
frequencies of Fusobacterium B (median=0.0%).
Animals with these communities were infrequent in
both colonies.

DISCUSSION
One of the techniques in animal husbandry that has
helped to reduce deaths due to infectious disease, and to
increase the likelihood that deaths are due to age rather
than other environmental factors, is the development of
specific pathogen free colonies with implemented
barrier conditions. Rodent colonies for biomedical
research began implementing procedures for deriving
specific pathogen free lineages in the 1980’s and
husbandry practices altered dramatically to include
barrier protocols [25, 26, 28]. The implementation of
barrier protocols has resulted in major changes to the
reported maximum lifespan for many mouse lineages,
for example 129/J mice were reported to have an
increase in lifespan of 22% from 648 days in 1966 to
791 days in 2009 [29]. While there may be a variety of
causes for this increased lifespan, most researchers and
colony managers agree that the implementation of
HEPA filtered air systems, controlled diets, and sealed
rack units have resulted in decreased infectious disease
spread and decreased stress for the animals. The
implementation of these husbandry practices was not
just beneficial to animal welfare, health and aging, it
has resulted in improved health for the caregivers, and
increased quality and repeatability of research between
research sites [25].
Establishment of nonhuman primate SPF colonies have
been largely driven by the needs of specific research
agendas and not to support the development of aging
studies. The most well-established SPF nonhuman
primate is the rhesus macaque which has been cleared
of tuberculosis, simian retrovirus (SRV), simian
immunodeficiency virus (SIV), and Herpes B virus
[30]. As opposed to our efforts, the main driving force
for the establishment of these SPF rhesus macaque
colonies has been to support SIV/AIDS research [30],
as well as clearing the species of a pathogen that is
potentially fatal to humans. A baboon colony that is
SPF for five herpesviruses, four retroviruses, simian
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virus 40, measles and monkey pox was established at
the Oklahoma Health Science Center [31], primarily to
support the use of baboons in transplantation studies
requiring immunosuppression. The Barshop marmoset
colony was the first new world monkey selfpropagating SPF colony to be developed. Marmosets
were selected as a species in which to develop an SPF
barrier colony for aging research because their lifespan,
size and social characteristics make them ideal for
biomedical research and specifically aging research.
Marmosets do not pose a zoonotic risk for human
caretakers and researchers since they are not carriers of
the herpes B virus that macaques carry [32].
The choice of pathogens to screen for and remove in the
development of the marmoset SPF colony was
complicated by our limited understanding of the
relationship of viral infections to disease in this species.
One of the viruses (CHV) has been proposed to be a
possible cause of lymphomas, however others dispute
this claim [33, 34]. The screen for viral, bacterial and
parasitic pathogen presence revealed few animals that
were free from all identified agents. Interestingly the
SPF colony was able to be derived without the need for
removing infants from the mother shortly after delivery
and nursery rearing with other infants, or the more
stringent cesarean derivation that has been implemented
in a number of SPF colonies [30, 31, 35]. Adult
marmosets were identified that were negative for both
viruses and the identified bacterial and parasitic
pathogens of interest. With the exception of one male,
all animals remained negative for the viruses, and few
were found to be positive for Giardia during the years
of follow-up. This is quite different from the viruses of
interest in Old World monkey SPF colonies such as
herpes B, which sporadically break through, appearing
in previously sera-negative animals either due to latent
tendencies or in utero transmission. Thus, the marmoset
SPF colony could be derived without the use of infant
isolation from the family group to maintain viral
negative animals.
Preventing bacterial and parasitic pathogens was not as
easy, with Giardia being prevalent in the conventional
colony and appearing sporadically in the SPF colony.
While Giardia can be treated with Tinidazole, the rate
of false positives in the assays and the inability to detect
it during the latency period made it more difficult to
remove from the SPF colony. However, Giardia was
noted to occur at significantly lower rates and did not
spread through the SPF colony. Animals in the SPF
colony that had a positive Giardia result were tested
regularly as follow-up and none had a repeat positive
result, whereas animals in the SNPRC colony did
repeatedly test positive and were treated with
Tinidazole. Further, we did not have deaths in the SPF
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colony
that were
directly
associated
with
gastrointestinal disease which has been associated with
intestinal infections including Giardia [36].
The Barshop marmoset colony quickly established as a
self-propagating SPF breeding colony in which infants
were successfully raised by their SPF parents. In fact,
the production and success of the SPF colony was
significantly better than the conventional colony. While
rotational hand-rearing and investment by the marmoset
staff in early infants did increase the rate of success for
triplet litters, the overall success of the colony was
better for all litter types. The elimination of specific
pathogens and maintenance in strict barrier conditions
increased infant survivorship and decreased juvenile
and early adult deaths. Of particular importance for
establishing aging research colonies, marmosets can be
bred and continually housed socially under barrier
conditions – something that is decidedly more difficult
to accomplish with large-bodied Old World monkeys.
There were differences in some blood chemistry values
between the SPF and conventional colonies. Most of the
blood and urinary values fell well within normal range
for marmosets. The SPF colony did exhibit significantly
decreased white blood cell, monocyte and neutrophil
count when compared to the conventional colony.
While typically within the normal range, the
conventional colony had individuals with values at the
top of the range. These results suggest that on average
the marmosets in the SPF colony had lower antigen
exposure rates than the conventional colony.
The Barshop colony had significantly increased early
and mid-adult age-specific survivorship when compared
to most other marmoset colonies. The results were
similar to those of the colony that reported the highest
average median and maximum life span [37]. One
interesting difference in the SPF barrier colony from
both the SNPRC conventional colony and the CLEA
colony is the lack of a sex difference in survivorship.
Nishijima et al. (2012) report significantly lower agespecific survival in marmoset females than in males, a
finding that we have also reported previously for the
SNPRC marmoset colony [38]. The reasons for this
difference are unclear.
The New England Primate Center previously reported
causes of death within their marmoset colony between
2004 and 2009 as primarily inflammatory bowel
disease, conspecific injury, and infectious disease of the
gut and kidney [21]. The primary causes of death for
marmosets under the age of 6 at SNPRC between 2002
and 2011 were irritable bowel disease and colitis [20].
These causes of death for animals under the age of 6
were not seen in the Barshop SPF colony. Coincident
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with these differences in causes of death is the striking
difference in the gastrointestinal tract microbiomes of
the SPF and SNPRC colonies. Whether these
differences are due to the selection of founding animals
with specific microbiomes, or to changes that occurred
after the colony was established is unknown. The
differences may also reflect differences in the environmental conditions and/or the exclusion of specific
organisms. It would certainly be interesting to know
whether the improved health in the barrier colony, and
the lack of deaths due to intestinal diseases are related
to the differences in microbial community composition.

CONCLUSIONS

The plateau effect for adult longevity depicted by the
barrier colony is presumably due to the decreased
exposure to infectious agents and pathogens rather than
genetic effects on longevity since the barrier colony was
founded from the SNPRC conventional colony. All of
the health and colony indicators suggest that
maintenance in a barrier reduced early mortality,
increased colony rate of growth, and supported
significantly healthier marmosets. The ability to detect
differences in lifespan and mortality rates in association
with colony management and husbandry techniques
may indeed be valuable for future aging research.

Specific pathogen free marmosets

A future question to address is the extent to which
barrier procedures, such as autoclaved water, irradiated
food, high air exchanges, and enhanced personal
protective equipment contributes to these improved
outcomes, as opposed to the simple fact of having a
closed colony. We have previously reported that we
have observed improvements in early-adult survivorship
when the SNPRC colony was retained as closed (20012006) and those improvements disappeared when the
colony was opened to importation of new animals to
support colony growth [21]. In addition, the CLEA
colony has been closed to new animals for over three
decades but does not report using barrier techniques
for maintenance. It is possible that simply preventing
the influx of pathogens from outside sources is enough
to increase longevity and health-span in marmosets and
that full barrier techniques are not necessary. However, almost all rodent models of aging and healthspan are maintained under barrier protocols, and the
ability to translate results from rodent experimentation
to primate models require barrier protocols to be
designed and evaluated for primates. While there is
certainly room for further enhancement and testing of
barrier techniques for use with marmosets, the Barshop
SPF barrier colony firmly supports that marmosets can
be bred and maintained in an environment ideal for
aging research, and the health and longevity of these
animals is improved over conventionally housed
animals.
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Marmosets offer a unique model for biomedical
research and for aging studies in particular. The shorter
lifespan, small size, and ease of care make them ideal as
a nonhuman primate model. The ability to successfully
create a specific pathogen free colony of breeding
marmosets offers the opportunity to broaden their use
by researchers to investigate causes of age related
decline and biological age related disease.

METHODS

The SPF barrier marmoset colony was begun at the
Barshop Institute for Longevity and Aging Studies,
University of Texas Health Science Center at San
Antonio in 2006. In order to populate this colony,
animals from the Southwest National Primate Research
Center were screened for several identified agents
associated with pathogenic outcomes. Blood from
animals of interest was screened for the presence of the
viruses GB virus-A (GBV) and Callitrichine Herpes
virus-3 (CHV) by the Lanford viral core at the Texas
Biomedical Research Institute [39, 40]. Marmoset
blood was obtained with EDTA anticoagulant. Plasma
was removed after centrifugation. The cell pellet was
suspended with PBS to 1 ml. DNA was purified from
the 200 µl of the cell suspension using a Qiagen miniDNA column purification kit. DNA was eluted in a
volume of 25 µl of water and the concentration was
determined by using a Nanodrop ND-1000. TaqMan
real time PCR amplification for CHV DNA was
performed with 200 ng of cell DNA using an ABI 7500
TaqMan machine with the ABI Fast Advance PCR
solution. The TaqMan primers and probe were designed
against the major internal repeat of CHV. The primers
and
probe
were:
forward
primer
(TGGGCCTAGTCTCCCCATAGA), reverse primer
(GTGAGGGAGTCCATAAGGAAACTTT), and a
Fam-Tamra labeled probe (CGCCTGTATGTCTTACT
GGGACCCCTG). The RT-PCR assay for GBV-A
RNA was a gel based assay. Multiple attempts to
develop a quantitative TaqMan RT-PCR were not
successful. The sequence of GBV-A was not available
from multiple isolates. The target region selected for
this assay was based on available sequences and was
variable (Buhk). Sequence of the target region from
animals within the SNPRC colony, confirmed the
sequence variation confounding the ability to develop a
probe for the detection of all isolates. The RT-PCR used
for this project employed a single round of 40 cycles of
amplification followed by detection of the product by
agarose gel electrophoresis and ethidium bromide
staining. RNA was purified from 50 µl of plasma using
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RNA-Bee following the manufacturer’s protocol. The
final RNA pellet was suspended in 50 µl of water and
10 µl was amplified using the Invitrogen RT-PCR
Superscript Kit for Long Templates. The primers
detected a 400 nucleotide region in the 5’untranslated
region (UTR) of marmoset GBV-A. The primers were:
forward primer (AGGGTTCGTAGGTGGTAAATCCC)
and reverse primer (TGCCACCAGGGGTCACCCGA
AG).
Fecal samples from candidate animals were evaluated
for the presence of Giardia spp., Cryptosporidium spp.,
Clostridium perfringens, helminths, parasitic ova,
enteropathic E. coli, Campylobacter spp., and
Trichimonas spp. through IDEXX commercial
veterinary screening services. In initial screenings of the
SNPRC colony no marmoset tested positive for the
presence of Campylobacter spp. or Trichimonas spp.
and these assays were dropped from further
assessments. Screening for all other pathogens was done
prior to colony formation and then periodically after the
formation of the SPF colony. The first SPF male-female
pair of marmosets was moved to the barrier facility at
the Barshop Institute July 2007. The initial formation of
the colony consisted of a total of 12 founder animals,
with animals entering between July 2007 and April
2010. In order to assess the maintenance of the colony
as specific pathogen free, viral screening occurred for
all animals six months after entry to the barrier and
sentry animals (one from each family group) were six
years after formation of the colony. Fecal collections to
assess the presence of Giardia, Cryptosporidium, and
Clostridium perfringens were done annually following
the formation of the colony.

entry or autoclaved. Water bottles were autoclaved
before use, and all water used in the room was
autoclaved. The paper placed under the cage to capture
waste was DACB neomycin coated cage liner
(Shepherd Specialty Paper, Watertown, TN) to decrease
the potential for aerosolized urinary product and
contamination between cages. Personal protective
equipment for the facility included standard shoe
covers, hair bonnet, face mask and gloves as well as a
disposable outer gown. Staff was required to enter the
barrier rooms prior to work with any other animals or
entry into other animal facilities. Clean scrubs were
required to enter the barrier spaces, and if a staff
member had already entered another animal room they
were required to shower before entering the marmoset
barrier.
SPF marmosets in the barrier were fed a purified diet to
prevent food borne pathogens from entering the colony.
The Harlan Teklad purified marmoset diet (TD99468)
used by SNPRC [41] was modified to be irradiated at
the production factory and double bagged in 1kg
portions. This purified diet was prepared under a hood
using gelatin as the setting agent and autoclaved water.
The food containers were sealed under the hood and
transported to a refrigerator in the animal room. Due to
the unusual nature of the facility food enrichment was
restricted within the barrier. An irradiated primate
enrichment mix consisting of nuts, seeds, and dried fruit
from Harlan Teklad was given daily. In cases of ill
animals, or animals that were deemed to need supplements, items were chosen that could be purchased in
sealed single use containers such as baby food or high
calorie nutrition drinks, and unused portions were
disposed of daily.

Barrier maintenance
The first barrier rooms of the colony were two 10’x 29’
rooms within the animal care facility at the Barshop
Institute located at the UT Health San Antonio Texas
Research Park. Rooms were equipped with bioBubble
units (Fort Collins CO, www.biobubble.com) consisting
of two HEPA filtered airshower power units providing
200-300 air changes per hour in the 10’ x 18’ animal
vivarium space (Figure 3A). The front entry of the room
contained clean PPE storage for entry into the screened
vivarium. Each room maintained a positive air pressure
to the outside hall. All items within the bioBubble and
entering the bioBubble area were considered clean and
rigorous SOP’s to ensure cleanliness were used. The
vivarium housed six family units consisting of at most
two adults, four independent offspring and two-three
dependent offspring in marmoset breeding cages
measuring (1.3 x 1.5 x 0.6m) made of stainless steel
specifically designed for this colony (LGL) (Figure 3B).
All items entering the barrier were sanitized prior to
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In May 2013 the SPF marmoset colony was moved to a
new Barrier space at the Barshop Institute (Figure 3C).
This new barrier space was 2850 ft2 decommissioned
and reconfigured BSL3 space in the animal vivarium.
This new barrier facility consisted of a pass-through
double door entry, a food preparation room, laboratory
procedure room, four animal holding rooms (~180ft2
each), a surgical suite, and 2 autoclave entry areas. The
isolated air filtration system in this space was modified
such that instead of HEPA filtration preventing
contaminants from leaving the space the filtration
prevented contaminants from entering the space. The
entire space once entering through the pass through
double door entry was considered clean barrier space.
The air exchange in this facility was also maintained at
the higher rate of 200 changes per hour. Humidifiers
(Humidifirst) were added to each animal holding room
that use double filtered RO water to maintain room
humidity between 35 and 40%. Barrier protocols were
maintained similarly to the bioBubble space and all
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other general maintenance and husbandry protocols
were adopted from SNPRC’s marmoset colony [42].
The research adhered to ethical guidelines for
primatological research as outlined by the American
Society of Primatologists and the Institutional Animal
Care and Use Committee at the University of Texas
Health Science Center San Antonio and SNPRC.

Additionally, urine was collected for these age- and sexmatched individuals and basic urinary values were
assessed using a strip test to establish values of protein,
glucose, ketone, specific gravity and presence of blood
in the urine. Results from the two colonies were
compared statistically using SPSS 23.0 repeated
measures ANOVA.

Health monitoring

To examine longevity in the SPF colony, age at death
for individuals in the barrier were compared to the
SNPRC colony records for age of death during the same
date frame. We compared survival in a population of
247 barrier animals (115 females and 132 males) versus
a population of 370 conventionally housed animals (173
females and 197 males) over a 10-year period. The final
date of comparison was August 2016 and animals were
censored from the data if they were still alive at the end
of date frame, if they had been transferred to another

To compare the health outcomes for SPF marmosets
maintained in a barrier to conventionally housed
marmosets we evaluated blood CBC and blood
chemistry of all animals in the barrier to age and sex
matched animals maintained in the SNPRC marmoset
breeding colony. All of the blood counts were done in
the Tardif lab by a single technician, and the blood
chemistry samples were sent to IDEXX for evaluation.

Figure 3. (A) Barrier space at the Barshop Institute with bioBubble airshower units. (B) Stainless steel marmoset breeding cage
(LG). (C) Layout of converted BSL3 Barrier space for marmoset colony.
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primate facility, or if death was associated with an
experimental protocol. For marmosets, the first two
weeks of life present a high risk of neonatal death and
are typically removed from longevity analyses, as we
did here. Survivorship curves were estimated using
Kaplan-Meier estimation, Cox proportional hazard
model and Fisher’s exact test with males and females
evaluated separately.

detection assays and Dorah Mtui for preparing fecal
samples for 16S rRNA sequencing. Sequencing
facilities in the IBEST Genome Resources Core were
supported by NIH P30GM103324.

Microbial community analysis

FUNDING

To evaluate the microbial diversity of the marmoset
gastrointestinal tract, 38 marmosets living in the barrier
colony and 16 marmosets from the conventionally
housed SNPRC colony were sampled between October,
2011 and April, 2012. A fecal sample was taken from
each marmoset by inserting a mini e-swab (Copan
Diagnostics) into the rectum. E-swabs were stored in
Amies transport medium and immediately frozen at 80° C. Samples were mailed to the University of Idaho
on dry ice and stored at
-80° C. Using methodology
that is standard at the University of Idaho [43], DNA
was extracted from the fecal samples, and the V1-V3
region of the 16S ribosomal RNA gene (universal 16S
rRNA primers 27F and 534R) was amplified and then
sequenced by an Illumina MiSeq. Sequence reads were
processed for quality and assigned to best taxonomic
level by the IBEST Genomics Resources Core
(http://www.ibest.uidaho.edu/cores/genomic-resourcescore/). The depth of coverage for each community was
sufficient to detect taxa that constituted ≈0.01% of a
community. Taxa that occurred at low frequency were
removed from further consideration (ie: if a taxon had
no single sample with a frequency greater than 5%).

This work was supported with funding from the
Barshop Institute for Longevity and Aging Studies and
NIH R24OD010933.

The R statistical package, vegan, was used to calculate
alternative Gower distances among samples based upon
taxon frequencies, and these distances were clustered by
a hierarchical algorithm, hclust, using complete linkage.
The number of clusters was determined by eye and
confirmed using silhouette plots. The number of
samples from barrier and conventional marmosets were
enumerated for each cluster, and Fisher’s exact test
using simulated p-values was used to test for random
associations between cluster and colony type. A
stepwise discriminant analysis was used to determine
whether specific bacteria contribute to the placement of
samples within clusters.
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